Sector

Healthcare Insider Trading Activity

Every SEC Form 4 insider transaction reported by Healthcare companies — biotech, pharmaceuticals, medical devices, and providers — sourced directly from SEC EDGAR and updated as new filings are accepted.

By · SEC Form 4 & insider trading data analysts
Last updated:

Quick Answer

Are Healthcare insiders buying or selling?

Healthcare insiders reported 17,367 open-market buys ($36.9B) and 58,497 sells ($203.5B) across 75,864 Form 4 filings from 1,182 companies — a net selling position of $166.6B.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 20, 2026)

Total Form 4 filings
75,864
SEC EDGAR
Companies
1,182
Insider buys (17,367)
$36.9B
Insider sells (58,497)
$203.5B

Sector sentiment

Net selling

Net insider flow of $166.6B in net selling across 10,242 insider filers.

Most active Healthcare companies

#CompanyForm 4 filings
1MRNAModerna, Inc.821
2NTRANatera, Inc.699
3BLFSBIOLIFE SOLUTIONS INC680
4UTHRUNITED THERAPEUTICS Corp620
5VRTXVERTEX PHARMACEUTICALS INC / MA530
6EWEdwards Lifesciences Corp495
7DXCMDEXCOM INC487
8TWSTTwist Bioscience Corp481
9TDOCTeladoc Health, Inc.465
10RMDRESMED INC412

Recent Healthcare insider transactions

DateTickerInsiderTypeValue
Jul 20, 2026ANIXTitterton Lewis H jrDirectorPurchase$41.6K
Jul 20, 2026ARTVPeter KolchinskyDirector, 10% OwnerPurchase$1.4M
Jul 20, 2026CLOVKaren SoaresChief Legal OfficerSale$233.2K
Jul 20, 2026AKTSKen HerrmannDirectorSale$77.3K
Jul 20, 2026CBIOTomas KiselakDirector, 10% OwnerPurchase$12.4M
Jul 20, 2026CERSVivek K JayaramanChief Executive OfficerSale$52.7K
Jul 20, 2026DNASteven P. CoenChief Financial OfficerSale$5.9K
Jul 20, 2026UTHRMartine A RothblattChairperson & CEOSale$5.1M
Jul 20, 2026HIMSOluyemi OkupeChief Financial OfficerSale$229.2K
Jul 20, 2026VEEVThomas D. SchwengerPres. & Chief Customer OfficerSale$1.0M
Jul 20, 2026BCDAPeter AltmanPresident and CEOPurchase$415
Jul 20, 2026INCYSteven H SteinCMO & Head of Late-Stage Dev.Sale$215.3K
Jul 20, 2026INCYMohamed Khairie IssaEVP, Head of U.S. CommercialSale$125.7K
Jul 20, 2026LYELInnovative Cellular Therapeutics Holdings Ltd10% OwnerSale$137
Jul 20, 2026DOCSSiddharth SitaramChief Accounting OfficerSale$38.1K
Jul 20, 2026MLTXKristian ReichChief Scientific OfficerSale$322.3K
Jul 20, 2026MPLTJonathan GillisCAO and Interim CFOSale$1.4M
Jul 18, 2026MPLTChristopher A. KroegerChief Executive OfficerSale$5.4M
Jul 18, 2026MPLTJames Woodruff LillieChief Scientific OfficerSale$673.6K
Jul 18, 2026LYELInnovative Cellular Therapeutics Holdings Ltd10% OwnerSale$137.3

Showing the 20 most recent filings. Screen every Healthcare filing.

Healthcare insider trading FAQ

Are Healthcare insiders buying or selling?

Across 75,864 SEC Form 4 filings in the Healthcare sector, insiders reported 17,367 open-market purchases totaling $36.9B and 58,497 sales totaling $203.5B. That is a net selling position of $166.6B.

Which Healthcare companies have the most insider activity?

Moderna, Inc. (MRNA), Natera, Inc. (NTRA), BIOLIFE SOLUTIONS INC (BLFS), UNITED THERAPEUTICS Corp (UTHR), VERTEX PHARMACEUTICALS INC / MA (VRTX) lead the Healthcare sector by Form 4 filing count.

How many companies file Form 4s in the Healthcare sector?

1,182 Healthcare companies have reported SEC Form 4 insider transactions on Trabud, from 10,242 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly.

Where does Trabud get Healthcare insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Learn

What is SEC Form 4?

The filing behind every transaction here

Guide

How to Track Insider Trading

A practical workflow for following Form 4 activity

Use Case

Insider Buying Signals

How investors read insider purchases

Screen every Healthcare insider filing

Filter all 75,864 Healthcare Form 4 filings by transaction value, insider role, market cap, and date — or ask Trabud's AI agent in plain English.

Open the Healthcare screener